Live from the NIH registry
Studies recruiting near McAllen right now
Top 25 of 135 recruiting studies, sorted by proximity — each links to its official registry page
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Edinburg, Texas (7.4 mi)
· Sponsor: TG Therapeutics, Inc.
A Study of ZL-1310 in Participants With Selected Solid Tumors
Solid Tumors
Phase 1, Phase 2
Interventional 166 participants sought
Texas Oncology - Central South — McAllen, Texas (1.8 mi)
· Sponsor: Zai Lab (Shanghai) Co., Ltd.
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
HCA Research Institute — McAllen, Texas (1.8 mi)
· Sponsor: Novo Nordisk A/S
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
Ventricular Ejection Fraction, LVF
N/A
Observational 2,000 participants sought
South Heart Clinic — Weslaco, Texas (16.5 mi)
· Sponsor: Peerbridge Health, Inc
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Overweight, Obesity
Phase 3
Interventional 900 participants sought
Texas Valley Clinical Research (TVCR) - Mission — Mission, Texas (4.9 mi)
· Sponsor: Eli Lilly and Company
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 245 participants sought
Research Site — Edinburg, Texas (7.4 mi)
· Sponsor: AstraZeneca
A Randomized Control Trial of Conversations Advancing Resilience and Empowerment (CARE) Intervention
Quality of Life, Health Promotion
N/A
Interventional 200 participants sought
The University of Texas at Rio Grande Valley — Edinburg, Texas (7.4 mi)
· Sponsor: University of Texas Rio Grande Valley
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — McAllen, Texas (1.8 mi)
· Sponsor: Akero Therapeutics, Inc
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Edinburg, Texas (7.4 mi)
· Sponsor: 89bio, Inc.
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Texas Valley Clinical Research - Mission, TX — Mission, Texas (4.9 mi)
· Sponsor: Sparrow Pharmaceuticals
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
Phase 3
Interventional 11,300 participants sought
Research Site — McAllen, Texas (1.8 mi)
· Sponsor: AstraZeneca
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Biopharma Informatic-McAllen — McAllen, Texas (1.8 mi)
· Sponsor: Amgen
Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
Graves' Disease
Phase 2
Interventional 232 participants sought
Site 128 — Edinburg, Texas (7.4 mi)
· Sponsor: Yarrow Bioscience, Inc.
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
STCC at DHR Health Institute for Research and Development — Edinburg, Texas (7.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
Sjögren's Syndrome
Phase 3
Interventional 844 participants sought
Biopharma Informatic - Ridge Road - PPDS — McAllen, Texas (1.8 mi)
· Sponsor: Amgen
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Metastatic Non-small Cell Lung Cancer
Phase 3
Interventional 734 participants sought
DHR Health Oncology Institute — Edinburg, Texas (7.4 mi)
· Sponsor: NovoCure GmbH
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Valley Retina Institute, PA — McAllen, Texas (1.8 mi)
· Sponsor: Boehringer Ingelheim
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Healthy
Phase 3
Interventional 6,000 participants sought
Dr. Ruben Aleman and Associates — McAllen, Texas (1.8 mi)
· Sponsor: Pfizer
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Progressive Pulmonary Fibrosis, Interstitial Lung Disease
Phase 3
Interventional 698 participants sought
A & A Research Consultants, LLC — McAllen, Texas (1.8 mi)
· Sponsor: United Therapeutics
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
Chemotherapy Induced Neuropathic Pain, Chemotherapy Induced Pain Neuropathy
Phase 2
Interventional 240 participants sought
Central Recruiting Site — McAllen, Texas (1.8 mi)
· Sponsor: Dogwood Therapeutics Inc.
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age
Chickenpox
Phase 3
Interventional 911 participants sought
GSK Investigational Site — Pharr, Texas (4.4 mi)
· Sponsor: GlaxoSmithKline
Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome
Cushing Syndrome
Phase 2
Interventional 12 participants sought
Texas Valley Clinical Research — Weslaco, Texas (16.5 mi)
· Sponsor: RECORDATI GROUP
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
STCC at DHR Health Institute for Research and Development — Edinburg, Texas (7.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
STCC at DHR Health Institute for Research and Development — Edinburg, Texas (7.4 mi)
· Sponsor: SWOG Cancer Research Network
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Metabolic Dysfunction-associated Steatohepatitis
Phase 2
Interventional 160 participants sought
South Texas Research Institute (STRI) — Edinburg, Texas (7.4 mi)
· Sponsor: Eccogene